A Gene Therapy Study in Patients With Gaucher Disease Type 1

Clinical trial NCT05324943 · COMPLETED

Trial details

NCT number: NCT05324943
Sponsor: Spur Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gaucher Disease, Type 1

Start date: 2022-04-15
Primary completion: 2024-12-04
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.